Integral Health Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Integral Health Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-150,000	Closed	-$6.36M	–	96
2024 Q3	$6.36M	Buy	+150,000	New	+$6.36M	0.72%	39
2024 Q2	–	Sell	-225,000	Closed	-$7.97M	–	100
2024 Q1	$7.97M	Buy	+225,000	New	+$6.03M	0.74%	52
2023 Q4	–	Sell	-130,000	Closed	-$2.7M	–	94
2023 Q3	$2.7M	Buy	+130,000	New	+$3.57M	0.37%	61

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Integral Health Asset Management's TNDM Position: Q4 2024 in Review

Integral Health Asset Management sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 150,000 shares — an estimated $6.36M sold.

Integral Health Asset Management first reported a position in TNDM in Q3 2023 and held it in 3 quarters. The position peaked at $7.97M in Q1 2024. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

Integral Health Asset Management reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
Integral Health Asset Management sold 150,000 Tandem Diabetes Care shares in Q4 2024, an estimated $6.36M.
Integral Health Asset Management first reported a position in Tandem Diabetes Care in Q3 2023 and held it in 3 quarters.
Integral Health Asset Management's Tandem Diabetes Care position peaked at $7.97M in Q1 2024.
316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Integral Health Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.